+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Fusilev- Drug Insight, 2019

  • PDF Icon

    Report

  • 35 Pages
  • January 2019
  • Region: Global
  • DelveInsight
  • ID: 4038433
UP TO OFF until Dec 31st 2024
Introduction

This pharmaceuticals report, "Fusilev Drug Insight, 2019" highlights the drug marketed details and the Global API Manufacturers details across the globe along with their location. The report covers the Global Market Assessment of the Fusilev covering the historical global sales and also provides the Fusilev sales estimation during the forecasted period (2019-2021). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Fusilev and emerging therapies in this space.

Methodology

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by the research team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope
  • A review of the Fusilev, based on information derived from company and industry-specific sources
  • Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
  • Coverage of the Drug Master Files and API Manufacturers by country
  • Patent Expiry Timeline and Exclusivity Details
  • Route of Synthesis of the API
  • Forecasted Sales Figure from 2019-2021
  • Market competition and emerging therapies
  • SWOT Analysis

Reasons to Buy
  • Establish a comprehensive understanding of Fusilev
  • Access to drug`s API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around drug`s patents for the major markets- US and EU
  • Understand Fusilev`s current and future growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for the drug
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as the drug
  • Identify opportunities in the same area as Fusilev with the publisher's SWOT analysis

Table of Contents

1. Report Introduction

2. Fusilev- Overview
  • Product Description

  • Route of Synthesis

  • Mechanism of Action

  • Pharmacology

  • Pharmacodynamics

  • Pharmacokinetics

  • Adverse Reactions

  • Regulatory Milestones by Region

  • Deals and Partnerships


3. Product Details

4. Fusilev Sales Assessment
  • Historical Sales

  • Forecasted Sales


5. Patent Details

6. Global API Manufacturers Assessment
  • Active Pharmaceutical Ingredient (API) Manufacturers by Country

  • Active Pharmaceutical Ingredient (API) Manufacturers by Region


7. Market Competition

8. Emerging Therapies
8.1 Drug 1: Company 1
  • Product Description

  • Research and Development

  • Product Development Activities


9. SWOT Analysis

Appendix

Methodology

Consulting Services

About the Publisher

Contact Us

Disclaimer